You are here

News and Events

In an effort to educate the transportation industry and others that provide service in accordance with the Department's drug and alcohol testing programs, our staff participates in conferences, trainings and seminars throughout the country. Events, dates, locations, and registration information will appear here as it becomes available.
 
  • On September 22, 2017 a Senior Policy Advisor will provide an overview presentation and training in Lexington, KY for the American Association of Medical Review Officers.  The training will focus on regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry.

  • On August 23, 2017 the Acting Director of the Office of Drug and Alcohol Policy and Compliance will be a guest speaker at the Substance Abuse Program Administrators’ Association annual conference in Henderson, NV.  This is a non-profit trade association that includes laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will be an update to the DOT’s regulated drug and alcohol testing efforts.

  • On August 9, 2017 the Acting Director of the Office of Drug and Alcohol Policy and Compliance and the Drug and Alcohol Program Managers from the Pipelines and Hazardous Material Safety Administration and the Federal Motor Carrier Safety Administration will be guest speakers at the Gas Operations Technical & Leadership Summit in Rochester, MN.  The summit is sponsored by the Midwest Energy Association, a consortium of energy delivery industry organizations.  Topics that will be discussed at the conference will be an update to the DOT, PHMSA and FMCSA’s regulated drug and alcohol testing efforts.

  • On July 13, 2017, the Office of Drug and Alcohol Policy and Compliance, with the Office of General Counsel, issued a 49 CFR Part 40 Question and Answer.  Like all ODAPC/OGC Qs & As, this Q&A constitutes official and authoritative guidance and interpretation concerning Part 40.  The Q&A issued today is available on our website at: https://www.transportation.gov/odapc/part40QandA.  The Q&A explains whether the United States Coast Guard is a DOT Agency with respect to the DOT’s drug and alcohol testing regulation, 49 CFR Part 40.

  • On May 16-19, 2017, Acting Director will be a guest speaker at the Drug and Alcohol Testing Industry Association (DATIA) annual conference in Orland, Florida.  DATIA is a non-profit organization that represents the interests of laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will include updates to the DOT’s regulated drug and alcohol testing efforts.

  • On April 18-20, 2017, the Acting Director and a Senior Policy Advisor for the Office of Drug and Alcohol Policy and Compliance will be guest speakers at the Federal Transit Administration’s Annual Drug and Alcohol Program National Conference in New Orleans, LA.  Topics that will be discussed at the conference will be an update to the DOT’s regulated drug and alcohol testing efforts.

  • On April 8, 2017 a Senior Policy Advisor will provide an overview presentation and training in Washington, DC for the American Association of Medical Review Officers.  The training will focus on regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry.

  • On February 4, 2017 the Acting Director of the Office of Drug and Alcohol Policy and Compliance will provide an overview presentation and training in San Diego, CA for the American Association of Medical Review Officers.  The training will focus on regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry.

  • On January 23, 2017 ODAPC publishes a Notice of Proposed Rulemaking.  The NPRM proposes to amend its drug-testing program regulation to add four opioids (hydrocodone, hydromorphone, oxymorphone, and oxycodone) to its drug-testing panel; add methylenedioxyamphetamine (MDA) as an initial test analyte; and remove methylenedioxyethylamphetamine, (MDEA) as a confirmatory test analyte.  The proposed revision of the drugtesting panel is intended to harmonize with the revised Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This proposal also adds clarification to certain drug-testing program provisions where necessary, removes outdated information in the regulations that is no longer needed, and proposes to remove the requirement for employers and Consortium/Third Party Administrators to submit blind specimens.

  • On December 8, 2016, the Acting Director for the Office of Drug and Alcohol Policy and Compliance will provide an overview presentation and training for Medical Review Officers (MRO) in Las Vegas, Nevada for the American Association of Medical Review Officers. The training will focus on the role of MROs, who must be licensed physicians.  In addition, the regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry will be covered.  We provide a program overview and will address areas of potential noncompliance that we have experienced with other MROs to assist in avoiding similar violations in the future.  Also, Juan Moya, the Federal Motor Carrier Safety Administration’s (FMCSA) Drug and Alcohol Program Manager will provide an overview presentation on FMCSA’s Final Rule on the National Drug and Alcohol Testing Clearinghouse for Commercial Truck and Bus Drivers that was published in the Federal Register on December 5, 2016.

  • On December 2, 2016FMCSA Establishes National Drug and Alcohol Testing Clearinghouse for Commercial Truck and Bus Drivers

  • On September 14, 2016, the Acting Director of the Office of Drug and Alcohol Policy and Compliance will be a guest speaker at the Substance Abuse Program Administrators’ Association annual conference in Louisville, Kentucky.  This is a non-profit trade association that includes laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will be an update to the DOT’s regulated drug and alcohol testing efforts.

  • On September 9-10, 2016, the Acting Director of the Office of Drug and Alcohol Policy and Compliance will provide an overview presentation and training in Orlando, FL for the American Association of Medical Review Officers.  The training will focus on regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry.

  • On August 8, 2016 ODAPC published a final rule.  This final rule amends the U.S. Department of Transportation’s (DOT) regulation to conform to recent legislation that changed the definition of the term ‘‘service agent’’ in the DOT drug and alcohol testing regulations. The final rule also revises the definition of ‘‘service agent’’ to include all entities that provide services for DOT mandated drug and alcohol programs.

  • On May 13-15, 2016, a Senior Policy Advisor from the Office of Drug and Alcohol Policy and Compliance will provide an overview presentation and training for Medical Review Officers in Chicago, Illinois, for the American Association of Medical Review Officers.  The training will focus on the role of Medical Review Officers, who must be licensed physicians.  In addition, the regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry will be covered in the presentation by our staff.  We will address areas of potential noncompliance that we have experienced with other Medical Review Officers to assist in avoiding similar violations in the future.

  • On April 26-29, 2016, the Acting Director will be a guest speaker a the Drug and Alcohol Testing Industry Association's (DATIA) Annual National Conference in Las Vegas, NV.  DATIA is a non-profit organization that represents the interests of laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will include updates to the DOT’s regulated drug and alcohol testing efforts.

  • On March 23-24, 2016, the Acting Director and a Senior Policy Advisor for the Office of Drug and Alcohol Policy and Compliance will be guest speakers at the Federal Transit Administration’s Annual Drug and Alcohol Program National Conference in Sacramento, California.  Topics that will be discussed at the conference will be an update to the DOT’s regulated drug and alcohol testing efforts.

  • On January 27, 2016 - the Department of Transportation (DOT) issued a decision and order under the Procedures for Transportation Workplace Drug and Alcohol Testing Programs that excludes a service agent, Mounir R. Khouri, from providing drug and alcohol testing services in any capacity to any DOT-regulated employer for a period of 5 years. Mr. Khouri provided Consortium/Third Party Administrator Services (C/TPA) and Medical Review Officer (MRO) services to DOT-regulated trucking companies. Mr. Khouri pled guilty to criminal charges that he made materially false statements that an MRO had reviewed drug test results, when a qualified MRO had not done so. This Federal Register publication serves as notice to the public that DOT-regulated employers or their service agents must stop using the services of Mounir R. Khouri for administering their DOT-regulated drug and/or alcohol testing programs. Visit the PIE web page.

  • On December 24,2015, the FMCSA announces, pursuant to 49 CFR 382.305, that it is reducing the minimum annual percentage rate for random controlled substances testing for drivers of commercial motor vehicles (CMVs) requiring a commercial driver's license (CDL) from the current rate of 50 percent of the average number of driver positions to 25 percent of the average number of driver positions, effective in calendar year 2016

  • On September 25, 2015the Acting Director of the Office of Drug and Alcohol Policy and Compliance will be a guest speaker at the Substance Abuse Program Administrators’ Association annual conference in Houston, Texas.  This is a non-profit trade association that includes laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will be updates to the DOT’s regulated drug and alcohol testing efforts.

  • On September 12, 2015, the Acting Director for the Office of Drug and Alcohol Policy and Compliance will provide training in Washington, DC, for the American Association of Medical Review Officers.  The training will provide education on regulatory requirements and best practices for reviewing and verifying drug test results of safety sensitive employees in the transportation industry.  The training will also provide education on areas of potential noncompliance that ODAPC has experienced with other Medical Review Officers to assist in avoiding similar violations in the future. 

  • On August 18, 2015, The Department of Transportation (DOT) issued a decision and order under the Procedures for Transportation Workplace Drug and Alcohol Testing Programs that excludes a service agent, Elizabeth ‘‘Betsy’’ Pope d/b/a  Eastgate Laboratory Testing, from providing drug and alcohol testing services in any capacity to any DOT regulated employer for a period of 5 years. Ms. Pope and her company provided Medical Review Officer services to DOT-regulated trucking companies when Ms. Pope was not qualified to act as a Medical Review Officer.  Read the Federal Register notice on the Public Interest Exclusion.

  • On June 3, 2015, the Acting Director will be a guest speaker a the Drug and Alcohol Testing Industry Association's (DATIA) Annual National Conference in Miami, FL.  DATIA is a non-profit organization that represents the interests of laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will include updates to the DOT’s regulated drug and alcohol testing efforts.

  • On April 28-30, 2015, the Acting Director and a Senior Policy Advisor for the Office of Drug and Alcohol Policy and Compliance will be guest speakers at the Federal Transit Administration’s Annual Drug and Alcohol Program National Conference in Atlanta, Georgia.  Topics that will be discussed at the conference will be an update to the DOT’s regulated drug and alcohol testing efforts.

  • On December 12-14, 2014, the Acting Director for the Office of Drug and Alcohol Policy and Compliance will provide an overview presentation and training in Las Vegas, NV, for the American Association of Medical Review Officers.  The training will focus on regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry.  The training will also provide education on areas of potential noncompliance that ODAPC has experienced with other Medical Review Officers to assist in avoiding similar violations in the future.

  • On September 26-28, 2014, a Senior Policy Advisor for the Office of Drug and Alcohol Policy and Compliance will provide training in Washington, DC, for the American Association of Medical Review Officers.  The training will provide education on regulatory requirements and best practices for reviewing and verifying drug test results of safety sensitive employees in the transportation industry.  The training will also provide education on areas of potential noncompliance that ODAPC has experienced with other Medical Review Officers to assist in avoiding similar violations in the future.
  • On September 25, 2014, the Acting Director of the Office of Drug and Alcohol Policy and Compliance will be a guest speaker at the Substance Abuse Program Administrators’ Association annual conference in Richmond, Virginia.  This is a non-profit trade association that includes laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will be updates to the DOT’s regulated drug and alcohol testing efforts.
  • On August 21, 2014, and September 12-13, 2014, the Acting Director of the Office of Drug and Alcohol Policy and Compliance will be a presenter at a conference for state, local and municipal employers who follow the Department of Transportation’s regulated drug and alcohol testing program.  The conference “Responsibilities, Risks & Realities for Government Employers - Medical and Drug Program Management” is being sponsored by the Illinois Department of Transportation. 
  • On December 12-14, 2014, the Acting Director for the Office of Drug and Alcohol Policy and Compliance will provide an overview presentation and training in Las Vegas, NV, for the American Association of Medical Review Officers.  The training will focus on regulatory requirements and best practices for reviewing and verifying drug test results for safety sensitive employees in the transportation industry.  The training will also provide education on areas of potential noncompliance that ODAPC has experienced with other Medical Review Officers to assist in avoiding similar violations in the future.
  • On September 26-28, 2014, a Senior Policy Advisor for the Office of Drug and Alcohol Policy and Compliance will provide training in Washington, DC, for the American Association of Medical Review Officers.  The training will provide education on regulatory requirements and best practices for reviewing and verifying drug test results of safety sensitive employees in the transportation industry.  The training will also provide education on areas of potential noncompliance that ODAPC has experienced with other Medical Review Officers to assist in avoiding similar violations in the future.
  • On September 25, 2014, the Acting Director of the Office of Drug and Alcohol Policy and Compliance will be a guest speaker at the Substance Abuse Program Administrators’ Association annual conference in Richmond, Virginia.  This is a non-profit trade association that includes laboratories, collection sites, medical review officers, substance abuse professionals, third-party administrators, and regulated employers.  Topics that will be discussed at the conference will be updates to the DOT’s regulated drug and alcohol testing efforts.
Updated: Friday, September 29, 2017
Submit Feedback >